UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 12, 2018
VEECO INSTRUMENTS INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
0-16244 |
|
11-2989601 |
Terminal Drive, Plainview, New York 11803
(Address of principal executive offices)
(516) 677-0200
(Registrants telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02 Results of Operations and Financial Condition.
On February 12, 2018, Veeco Instruments Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2017. In connection with the release and the related conference call, Veeco posted a presentation relating to its fourth quarter 2017 financial results on its website (www.veeco.com). Copies of the press release and presentation are furnished as Exhibit 99.1 and Exhibit 99.2 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit |
|
Description |
99.1 |
|
Press release issued by Veeco dated February 12, 2018 |
|
|
|
99.2 |
|
Veeco Q4 2017 Conference Call, February 12, 2018 |
The information in this report, including the exhibits, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities under that Section, nor shall this information or these exhibits be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
February 12, 2018 |
VEECO INSTRUMENTS INC. | |
|
| |
|
By: |
/s/ Gregory A. Robbins |
|
Name: Gregory A. Robbins | |
|
Title: Senior Vice President and General Counsel |
EXHIBIT INDEX
Exhibit |
|
Description |
99.1 |
|
|
|
|
|
99.2 |
|
NEWS
VEECO REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS
Fourth Quarter 2017 Highlights:
· Revenues of $143.4 million, compared with $93.6 million in the same period last year
· GAAP net loss of $5.6 million, or $0.12 loss per share
· Non-GAAP net income of $9.1 million, or $0.19 per diluted share
Full Year 2017 Highlights:
· Revenues of $484.8 million
· GAAP net loss of $44.8 million, or $1.01 loss per share
· Non-GAAP net income of $23.4 million, or $0.53 per diluted share
Plainview, N.Y., February 12, 2018 Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its fourth quarter and fiscal year ended December 31, 2017. Results are reported in accordance with U.S. generally accepted accounting principles (GAAP) and are also reported adjusting for certain items (Non-GAAP). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.
U.S. Dollars in millions, except per share data
|
|
4th Quarter |
|
Full Year |
| ||||||||
GAAP Results |
|
Q4 17 |
|
Q4 16 |
|
2017 |
|
2016 |
| ||||
Revenue |
|
$ |
143.4 |
|
$ |
93.6 |
|
$ |
484.8 |
|
$ |
332.5 |
|
Net income (loss) |
|
$ |
(5.6 |
) |
$ |
(5.0 |
) |
$ |
(44.8 |
) |
$ |
(122.2 |
) |
Diluted earnings (loss) per share |
|
$ |
(0.12 |
) |
$ |
(0.13 |
) |
$ |
(1.01 |
) |
$ |
(3.11 |
) |
|
|
4th Quarter |
|
Full Year |
| ||||||||
Non-GAAP Results |
|
Q4 17 |
|
Q4 16 |
|
2017 |
|
2016 |
| ||||
Net income (loss) |
|
$ |
9.1 |
|
$ |
3.8 |
|
$ |
23.4 |
|
$ |
(11.3 |
) |
Operating income (loss) |
|
$ |
10.5 |
|
$ |
3.3 |
|
$ |
31.3 |
|
$ |
(8.5 |
) |
Diluted earnings (loss) per share |
|
$ |
0.19 |
|
$ |
0.09 |
|
$ |
0.53 |
|
$ |
(0.29 |
) |
2017 was a transformational year for Veeco. We diversified our revenue base through the acquisition of Ultratech, completed a major manufacturing consolidation, and ended the year with strong bookings and historically high backlog, commented John R. Peeler, Chairman and Chief Executive Officer. Sales growth in the fourth quarter was driven primarily by shipment of our MOCVD and Laser Anneal systems, and we announced a large multi tool order for our EPIK® 868 from Focus Lightings for the production of high-volume light emitting diodes (LEDs).
Entering 2018, we expect to grow in all of our target markets, and we are seeing particularly healthy demand in Advanced Packaging, MEMS and RF Filter and Front-End Semiconductor markets, continued Mr. Peeler.
Lastly, as we announced on February 8, 2018, I am pleased to report that we have reached a mutually agreed settlement of the pending patent disputes with AMEC and SGL Carbon, and all legal actions related to this matter will be dismissed or withdrawn. We are back to normal operations in our MOCVD business, concluded Mr. Peeler.
Guidance and Outlook
The following guidance is provided for Veecos first quarter 2018:
· Revenue is expected in the range of $140 million to $165 million
· Non-GAAP operating income is expected in the range of $2 million to $10 million
· GAAP earnings (loss) per share are expected in the range of ($0.50) to ($0.32)
· Non-GAAP earnings (loss) per share are expected in the range of ($0.04) to $0.14
Please refer to the tables at the end of this press release for further details.
Conference Call Information
A conference call reviewing these results has been scheduled for today, February 12, 2018 starting at 5:00pm ET. To join the call, dial 1-800-239-9839 (toll free) or 1-323-794-2551 and use passcode 3939388. Participants may also access a live webcast of the call by visiting the investor relations section of Veecos website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.
About Veeco
Veeco (NASDAQ: VECO) is a leading manufacturer of innovative semiconductor process equipment. Our proven MOCVD, lithography, laser annealing, ion beam and single wafer etch & clean technologies play an integral role in producing LEDs for solid-state lighting and displays, and in the fabrication of advanced semiconductor devices. With equipment designed to maximize performance, yield and cost of ownership, Veeco holds technology leadership positions in all these served markets. To learn more about Veecos innovative equipment and services, visit www.veeco.com.
Forward-looking Statements
To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Managements Discussion and Analysis sections of Veecos Annual Report on Form 10-K for the year ended December 31, 2016 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.
-financial tables attached-
Veeco Contacts: |
|
|
|
Investors: |
Media: |
Anthony Bencivenga 516-677-0200 x1272 |
David Pinto 408-325-6157 |
abencivenga@veeco.com |
dpinto@veeco.com |
Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
|
|
Three months ended December 31, |
|
Year ended December 31, |
| ||||||||
|
|
2017 |
|
2016 |
|
2017 |
|
2016 |
| ||||
Net sales |
|
$ |
143,432 |
|
$ |
93,609 |
|
$ |
484,756 |
|
$ |
332,451 |
|
Cost of sales |
|
85,095 |
|
57,601 |
|
300,438 |
|
199,593 |
| ||||
Gross profit |
|
58,337 |
|
36,008 |
|
184,318 |
|
132,858 |
| ||||
Operating expenses, net: |
|
|
|
|
|
|
|
|
| ||||
Research and development |
|
24,318 |
|
17,471 |
|
81,987 |
|
81,016 |
| ||||
Selling, general, and administrative |
|
28,675 |
|
19,412 |
|
100,250 |
|
77,642 |
| ||||
Amortization of intangible assets |
|
13,753 |
|
3,434 |
|
35,475 |
|
19,219 |
| ||||
Restructuring |
|
2,246 |
|
1,646 |
|
11,851 |
|
5,640 |
| ||||
Acquisition costs |
|
1,510 |
|
|
|
17,786 |
|
|
| ||||
Asset impairment |
|
|
|
(142 |
) |
1,139 |
|
69,520 |
| ||||
Other, net |
|
(165 |
) |
(660 |
) |
(392 |
) |
223 |
| ||||
Total operating expenses, net |
|
70,337 |
|
41,161 |
|
248,096 |
|
253,260 |
| ||||
Operating income (loss) |
|
(12,000 |
) |
(5,153 |
) |
(63,778 |
) |
(120,402 |
) | ||||
Interest income (expense), net |
|
(4,753 |
) |
245 |
|
(17,122 |
) |
958 |
| ||||
Income (loss) before income taxes |
|
(16,753 |
) |
(4,908 |
) |
(80,900 |
) |
(119,444 |
) | ||||
Income tax expense (benefit) |
|
(11,137 |
) |
90 |
|
(36,107 |
) |
2,766 |
| ||||
Net income (loss) |
|
$ |
(5,616 |
) |
$ |
(4,998 |
) |
$ |
(44,793 |
) |
$ |
(122,210 |
) |
|
|
|
|
|
|
|
|
|
| ||||
Income (loss) per common share: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
(0.12 |
) |
$ |
(0.13 |
) |
$ |
(1.01 |
) |
$ |
(3.11 |
) |
Diluted |
|
$ |
(0.12 |
) |
$ |
(0.13 |
) |
$ |
(1.01 |
) |
$ |
(3.11 |
) |
|
|
|
|
|
|
|
|
|
| ||||
Weighted average number of shares: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
47,037 |
|
39,267 |
|
44,174 |
|
39,340 |
| ||||
Diluted |
|
47,037 |
|
39,267 |
|
44,174 |
|
39,340 |
|
Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)
|
|
December 31, |
|
December 31, |
| ||
|
|
2017 |
|
2016 |
| ||
Assets |
|
|
|
|
| ||
Current assets: |
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
279,736 |
|
$ |
277,444 |
|
Restricted cash |
|
847 |
|
|
| ||
Short-term investments |
|
47,780 |
|
66,787 |
| ||
Accounts receivable, net |
|
98,866 |
|
58,020 |
| ||
Inventories |
|
120,266 |
|
77,063 |
| ||
Deferred cost of sales |
|
16,060 |
|
6,160 |
| ||
Prepaid expenses and other current assets |
|
33,437 |
|
16,034 |
| ||
Total current assets |
|
596,992 |
|
501,508 |
| ||
Property, plant and equipment, net |
|
85,058 |
|
60,646 |
| ||
Intangible assets, net |
|
369,843 |
|
58,378 |
| ||
Goodwill |
|
307,131 |
|
114,908 |
| ||
Deferred income taxes |
|
2,953 |
|
2,045 |
| ||
Other assets |
|
25,310 |
|
21,047 |
| ||
Total assets |
|
$ |
1,387,287 |
|
$ |
758,532 |
|
|
|
|
|
|
| ||
Liabilities and stockholders equity |
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
| ||
Accounts payable |
|
$ |
50,318 |
|
$ |
22,607 |
|
Accrued expenses and other current liabilities |
|
60,339 |
|
33,201 |
| ||
Customer deposits and deferred revenue |
|
108,953 |
|
85,022 |
| ||
Income taxes payable |
|
3,846 |
|
2,311 |
| ||
Current portion of long-term debt |
|
|
|
368 |
| ||
Total current liabilities |
|
223,456 |
|
143,509 |
| ||
Deferred income taxes |
|
36,845 |
|
13,199 |
| ||
Long-term debt |
|
275,630 |
|
826 |
| ||
Other liabilities |
|
10,643 |
|
6,403 |
| ||
Total liabilities |
|
546,574 |
|
163,937 |
| ||
|
|
|
|
|
| ||
Total stockholders equity |
|
840,713 |
|
594,595 |
| ||
|
|
|
|
|
| ||
Total liabilities and stockholders equity |
|
$ |
1,387,287 |
|
$ |
758,532 |
|
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)
|
|
Non-GAAP Adjustments |
| ||||||||||
Three months ended December 31, 2017 |
|
GAAP |
|
Share-Based |
|
Amortization |
|
Other |
|
Non-GAAP |
| ||
Net sales |
|
$ |
143,432 |
|
|
|
|
|
|
|
$ |
143,432 |
|
Gross profit |
|
58,337 |
|
607 |
|
|
|
537 |
|
59,481 |
| ||
Gross margin |
|
40.7 |
% |
|
|
|
|
|
|
41.5 |
% | ||
Research and development |
|
24,318 |
|
(971 |
) |
|
|
|
|
23,347 |
| ||
Selling, general, and administrative and Other |
|
28,510 |
|
(2,668 |
) |
|
|
(196 |
) |
25,646 |
| ||
Net income (loss) |
|
(5,616 |
) |
4,420 |
|
13,753 |
|
(3,460 |
) |
9,097 |
| ||
|
|
|
|
|
|
|
|
|
|
|
| ||
Income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
$ |
(0.12 |
) |
|
|
|
|
|
|
$ |
0.19 |
|
Diluted |
|
(0.12 |
) |
|
|
|
|
|
|
0.19 |
| ||
Weighted average number of shares: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
47,037 |
|
|
|
|
|
|
|
47,109 |
| ||
Diluted |
|
47,037 |
|
|
|
|
|
|
|
47,208 |
|
Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)
Three months ended December 31, 2017 |
|
|
|
Restructuring |
|
2,073 |
|
Acquisition related |
|
1,510 |
|
Release of inventory fair value step-up associated with the Ultratech purchase accounting |
|
440 |
|
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting |
|
293 |
|
Non-cash interest expense |
|
2,805 |
|
Non-GAAP tax adjustment * |
|
(10,581 |
) |
Total Other |
|
(3,460 |
) |
* - The with or without method is utilized to determine the income tax effect of all Non-GAAP adjustments, as well as the exclusion of certain tax benefits attributed to the change in U.S. tax laws.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)
|
|
|
|
Non-GAAP Adjustments |
|
|
| ||||||
Three months ended December 31, 2016 |
|
GAAP |
|
Share-based |
|
Amortization |
|
Other |
|
Non-GAAP |
| ||
Net sales |
|
$ |
93,609 |
|
|
|
|
|
|
|
$ |
93,609 |
|
Gross profit |
|
36,008 |
|
316 |
|
|
|
362 |
|
36,686 |
| ||
Gross margin |
|
38.5 |
% |
|
|
|
|
|
|
39.2 |
% | ||
Research and development |
|
17,471 |
|
(292 |
) |
|
|
|
|
17,179 |
| ||
Selling, general, and administrative and Other |
|
18,752 |
|
(2,971 |
) |
|
|
(44 |
) |
15,737 |
| ||
Net income (loss) |
|
(4,998 |
) |
3,579 |
|
3,434 |
|
1,740 |
|
3,755 |
| ||
|
|
|
|
|
|
|
|
|
|
|
| ||
Income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
$ |
(0.13 |
) |
|
|
|
|
|
|
$ |
0.09 |
|
Diluted |
|
(0.13 |
) |
|
|
|
|
|
|
0.09 |
| ||
Weighted average number of shares: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
39,267 |
|
|
|
|
|
|
|
39,579 |
| ||
Diluted |
|
39,267 |
|
|
|
|
|
|
|
39,990 |
|
Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)
Three months ended December 31, 2016 |
|
|
|
Restructuring |
|
1,646 |
|
Acquisition related |
|
44 |
|
Asset impairment |
|
(142 |
) |
Accelerated depreciation |
|
362 |
|
Reclassification of cumulative translation gain from subsidiary liquidation |
|
(429 |
) |
Non-GAAP tax adjustment * |
|
259 |
|
Total Other |
|
1,740 |
|
* - The with or without method is utilized to determine the income tax effect of all Non-GAAP adjustments.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)
|
|
Three months ended |
|
Three months ended |
| ||
|
|
December 31, 2017 |
|
December 31, 2016 |
| ||
GAAP Net income (loss) |
|
$ |
(5,616 |
) |
$ |
(4,998 |
) |
Share-based compensation |
|
4,420 |
|
3,579 |
| ||
Amortization |
|
13,753 |
|
3,434 |
| ||
Restructuring |
|
2,073 |
|
1,646 |
| ||
Acquisition related |
|
1,510 |
|
44 |
| ||
Release of inventory fair value step-up associated with the Ultratech purchase accounting |
|
440 |
|
|
| ||
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting |
|
293 |
|
|
| ||
Asset impairment |
|
|
|
(142 |
) | ||
Accelerated depreciation |
|
|
|
362 |
| ||
Reclassification of cumulative translation gain from subsidiary liquidation |
|
|
|
(429 |
) | ||
Interest (income) expense |
|
4,753 |
|
(245 |
) | ||
Income tax expense (benefit) |
|
(11,137 |
) |
90 |
| ||
Non-GAAP Operating Income (loss) |
|
$ |
10,489 |
|
$ |
3,341 |
|
This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)
|
|
|
|
Non-GAAP Adjustments |
|
|
| ||||||
For the year ended December 31, 2017 |
|
GAAP |
|
Share-Based |
|
Amortization |
|
Other |
|
Non-GAAP |
| ||
Net sales |
|
$ |
484,756 |
|
|
|
|
|
|
|
$ |
484,756 |
|
Gross profit |
|
184,318 |
|
2,505 |
|
|
|
10,075 |
|
196,898 |
| ||
Gross margin |
|
38.0 |
% |
|
|
|
|
|
|
40.6 |
% | ||
Research and development |
|
81,987 |
|
(2,957 |
) |
|
|
|
|
79,030 |
| ||
Selling, general, and administrative and Other |
|
99,858 |
|
(12,851 |
) |
|
|
(466 |
) |
86,541 |
| ||
Net income (loss) |
|
(44,793 |
) |
24,396 |
|
35,475 |
|
8,368 |
|
23,446 |
| ||
|
|
|
|
|
|
|
|
|
|
|
| ||
Income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
$ |
(1.01 |
) |
|
|
|
|
|
|
$ |
0.53 |
|
Diluted |
|
(1.01 |
) |
|
|
|
|
|
|
0.53 |
| ||
Weighted average number of shares: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
44,174 |
|
|
|
|
|
|
|
44,247 |
| ||
Diluted |
|
44,174 |
|
|
|
|
|
|
|
44,486 |
|
Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)
For the year ended December 31, 2017 |
|
|
|
Restructuring |
|
9,971 |
|
Acquisition related |
|
13,583 |
|
Release of inventory fair value step-up associated with the Ultratech purchase accounting |
|
9,664 |
|
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting |
|
695 |
|
Asset impairment |
|
1,139 |
|
Accelerated depreciation |
|
180 |
|
Non-cash interest expense |
|
10,446 |
|
Non-GAAP tax adjustment * |
|
(37,310 |
) |
Total Other |
|
8,368 |
|
* - The with or without method is utilized to determine the income tax effect of all non-GAAP adjustments, as well as the exclusion of certain tax benefits attributed to the change in U.S. tax laws and the release of FIN48 reserves.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)
|
|
|
|
Non-GAAP Adjustments |
|
|
| ||||||
For the year ended December 31, 2016 |
|
GAAP |
|
Share-Based |
|
Amortization |
|
Other |
|
Non-GAAP |
| ||
Net sales |
|
$ |
332,451 |
|
|
|
|
|
|
|
$ |
332,451 |
|
Gross profit |
|
132,858 |
|
1,956 |
|
|
|
716 |
|
135,530 |
| ||
Gross margin |
|
40.0 |
% |
|
|
|
|
|
|
40.8 |
% | ||
Research and development |
|
81,016 |
|
(3,324 |
) |
|
|
|
|
77,692 |
| ||
Selling, general, and administrative and Other |
|
77,866 |
|
(10,433 |
) |
|
|
(1,537 |
) |
65,896 |
| ||
Net income (loss) |
|
(122,210 |
) |
15,713 |
|
19,219 |
|
75,954 |
|
(11,324 |
) | ||
|
|
|
|
|
|
|
|
|
|
|
| ||
Income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
$ |
(3.11 |
) |
|
|
|
|
|
|
$ |
(0.29 |
) |
Diluted |
|
(3.11 |
) |
|
|
|
|
|
|
(0.29 |
) | ||
Weighted average number of shares: |
|
|
|
|
|
|
|
|
|
|
| ||
Basic |
|
39,340 |
|
|
|
|
|
|
|
39,340 |
| ||
Diluted |
|
39,340 |
|
|
|
|
|
|
|
39,340 |
|
Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)
For the year ended December 31, 2016 |
|
|
|
Restructuring |
|
5,640 |
|
Acquisition related |
|
232 |
|
Asset impairment |
|
69,520 |
|
Accelerated depreciation |
|
716 |
|
Pension termination |
|
1,305 |
|
Reclassification of cumulative translation gain from subsidiary liquidation |
|
(429 |
) |
Non-GAAP tax adjustment * |
|
(1,030 |
) |
Total Other |
|
75,954 |
|
* - The with or without method is utilized to determine the income tax effect of all non-GAAP adjustments.
These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)
|
|
Year ended |
|
Year ended |
| ||
|
|
December 31, 2017 |
|
December 31, 2016 |
| ||
GAAP Net income (loss) |
|
$ |
(44,793 |
) |
$ |
(122,210 |
) |
Share-based compensation |
|
24,396 |
|
15,713 |
| ||
Amortization |
|
35,475 |
|
19,219 |
| ||
Restructuring |
|
9,971 |
|
5,640 |
| ||
Acquisition related |
|
13,583 |
|
232 |
| ||
Release of inventory fair value step-up associated with the Ultratech purchase accounting |
|
9,664 |
|
|
| ||
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting |
|
695 |
|
|
| ||
Asset impairment |
|
1,139 |
|
69,520 |
| ||
Accelerated depreciation |
|
180 |
|
716 |
| ||
Pension termination |
|
|
|
1,305 |
| ||
Reclassification of cumulative translation gain from subsidiary liquidation |
|
|
|
(429 |
) | ||
Interest (income) expense |
|
17,122 |
|
(958 |
) | ||
Income tax expense (benefit) |
|
(36,107 |
) |
2,766 |
| ||
Non-GAAP Operating Income (loss) |
|
$ |
31,325 |
|
$ |
(8,486 |
) |
This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in millions, except per share amounts)
(unaudited)
|
|
|
|
|
|
|
|
Non-GAAP Adjustments |
|
|
|
|
|
|
| ||||||||
Guidance for the three months ending March 31, 2018 |
|
GAAP |
|
Share-based |
|
Amortization |
|
Other |
|
Non-GAAP |
| ||||||||||||
Net sales |
|
$ |
140 |
|
- |
|
$ |
165 |
|
|
|
|
|
|
|
$ |
140 |
|
- |
|
$ |
165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Gross profit |
|
47 |
|
- |
|
58 |
|
1 |
|
|
|
|
|
48 |
|
- |
|
59 |
| ||||
Gross margin |
|
33 |
% |
- |
|
35 |
% |
|
|
|
|
|
|
34 |
% |
- |
|
36 |
% | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net income (loss) |
|
$ |
(23 |
) |
- |
|
$ |
(15 |
) |
4 |
|
13 |
|
4 |
|
$ |
(2 |
) |
- |
|
$ |
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Income (loss) per diluted common share |
|
$ |
(0.50 |
) |
- |
|
$ |
(0.32 |
) |
|
|
|
|
|
|
$ |
(0.04 |
) |
- |
|
$ |
0.14 |
|
Weighted average number of shares |
|
47 |
|
|
|
47 |
|
|
|
|
|
|
|
47 |
|
|
|
47 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)
(in millions)
(unaudited)
Guidance for the three months ending March 31, 2018 |
|
|
|
|
|
|
| ||
GAAP Net income (loss) |
|
$ |
(23 |
) |
- |
|
$ |
(15 |
) |
Share-based compensation |
|
4 |
|
- |
|
4 |
| ||
Amortization |
|
13 |
|
- |
|
13 |
| ||
Restructuring |
|
1 |
|
- |
|
1 |
| ||
Acquisition related |
|
1 |
|
- |
|
1 |
| ||
Interest expense, net |
|
5 |
|
- |
|
5 |
| ||
Income tax expense (benefit) |
|
1 |
|
- |
|
1 |
| ||
Non-GAAP Operating Income |
|
$ |
2 |
|
- |
|
$ |
10 |
|
Note: Amounts may not calculate precisely due to rounding.
These table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.
These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP
financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making.In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Safe Harbor To the extent that this presentation discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These items include the risk factors discussed in the Business Description and Management's Discussion and Analysis sections of Veeco's Annual Report on Form 10-K for the year ended December 31, 2016 and subsequent Quarterly Reports on form 10Q and current reports on Form 8-K. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.
CEO Introduction John Peeler
19¢ Non-GAAP EPS $143M Revenue Q4 2017 Highlights Bookings up 3rd consecutive quarter; backlog building Revenue up 9% from previous quarter Strongest quarter of the year in Non-GAAP operating income Non-GAAP EPS above high end of guided range $179M Bookings Q4 Results Note: A reconciliation of GAAP to Non-GAAP financial measures may be found in Back-up & Reconciliation Tables $10.5M Non-GAAP Op Income Executed well with positive momentum
2017: A Transformational Year Positioned to Grow Expanded Market Reach with Complementary Acquisition Closed Ultratech acquisition; integration progressing well Synergies greater than originally expected Executed Manufacturing Consolidation New Jersey manufacturing consolidation complete Generating $4M in annualized cost savings Poised to Diversify Revenues; Accelerate Profitable Growth Delivered 40.6% Non-GAAP gross margin in 2017 Bookings trends point to growth and diversification in 2018
CFO Financial Review Sam Maheshwari
Q4 2017 Revenue by End Market and Geography Bookings growth should lead to more diversified revenue mix Bookings grew to ~$179M Building backlog for 6 quarters in a row Growth in Front-End Semi and AP, will lead to more diverse 2018 China, Blue LED accounted for 13% of total Veeco revenue Mix By End Market By Geography 9% Advanced Packaging, MEMS & RF Filters 24% Scientific & Industrial 58% LED Lighting, Display & Compound Semi $143M 53% Rest of World 18% China 14% EMEA 15% United States 9% Front-End Semi Geographically diverse revenue streams ROW driven by LED sales into South East Asia, South Korea and Taiwan Note: Amounts may not calculate precisely due to rounding
2018: Growing Our Way to More Diversified Revenue Mix 15% - 20% Advanced Packaging, MEMS & RF Filters 15% - 20% Scientific & Industrial 15% - 20% Front-End Semi 40% - 50% LED Lighting, Display & Compound Semi Markets Mix By End Market Higher Growth Areas We expect 2018 to be a growth year for Veeco in all 4 market segments Strongest growth in Front-End Semi and Advanced Packaging Leading to a more balanced revenue mix 2017 2018 2017 2018 Note: Amounts may not calculate precisely due to rounding Revenue Front-End Semi Advanced Packaging, MEMS & RF Filters
Non-GAAP GAAP P&L Highlights Note: Amounts may not calculate precisely due to rounding A reconciliation of GAAP to Non-GAAP financial measures is contained in the Back Up & Reconciliation Tables ($M) Q3 17 Q4 17 2017 Q3 17 Q4 17 2017 Revenue $131.9 $143.4 $484.8 $131.9 $143.4 $484.8 Gross Profit 53.1 58.3 184.3 55.8 59.5 196.9 % 40.2% 40.7% 38.0% 42.3% 41.5% 40.6% R&D 24.1 24.3 82.0 23.2 23.3 79.0 SG&A & Other 29.6 28.5 99.9 25.7 25.6 86.5 Operating Income/(Loss) (18.9) (12.0) (63.8) 6.8 10.5 31.3 Net Income/(Loss) (21.9) (5.6) (44.8) 4.3 9.1 23.4 Earnings/(Loss) Per Share ($0.47) ($0.12) ($1.01) $0.09 $0.19 $0.53 6th consecutive quarter of revenue growth Non-GAAP gross margin benefiting from favorable product mix
DSO (days) 78 62 DOI 133 130 DPO 61 54 ($M) Q3 17 Q4 17 Cash & Short-Term Investments 321 328 Accounts Receivable 114 99 Inventories 114 120 Accounts Payable 54 50 Long-Term Debt 273 276 Cash Flow from Operations 25 19 Balance Sheet Highlights Note: Amounts may not calculate precisely due to rounding
Q1 2018 Guidance Revenue $140M$165M $140M$165M Gross Margins 33%35% 34%36% Net Income (Loss) ($23M)($15M) ($2M)$6M Earnings Per Share ($0.50)($0.32) ($0.04)$0.14 Non-GAAP Operating Income $2M$10M Non-GAAP GAAP Note: A reconciliation of GAAP to Non-GAAP financial measures is contained in the Back Up & Reconciliation Tables
Business Update & Outlook
Multiple Veeco Technologies Serve Growing Markets *Source: Various industry reports and company estimates Veeco Technologies: MOCVD Lithography Wet Etch/Clean Laser Anneal Ion Beam MBE 3D Inspection ALD ~50% Growth from 2017 to 2020 Growth of Veecos Served Markets From 2017 to 2020* $1.2B $1.8B Markets Advanced Packaging, MEMS & RF Filters LED Lighting, Display & Compound Semi Front-End Semi Scientific & Industrial Growth Drivers
Advanced Packaging, MEMS & RF Filters Source: TechSearch International & IC Insights 2017 Veeco Advanced Packaging Revenue 2017 2020 16% CAGR WLP Significant Increase in Demand for WLP Applications Reflects new customers or application penetrations 2016 WLP Wafer Level Packaging ADAS Advanced Driver Assisted Systems Applicable Technologies: MOCVD Lithography Wet Etch/Clean Laser Anneal Ion Beam MBE 3D Inspection ALD Broad-Based Growth Vectors Mobile devices and connectivity trends Automotive electronics growth, including ADAS Big Data Processing 5G infrastructure deployment in 2019 and 2020
Non General-Lighting Areas Such as Photonics and RF Driving Meaningful Growth VCSELs & Laser Diodes Micro-LEDs & Fine Pitched Displays 5G driven RF devices Power Electronics LED Lighting, Display & Compound Semi Veeco Remains the LED Market Leader 55% market share for GaN LED* Fab utilization worldwide > 85%; market to remain robust * Source IHS, Veeco VCSEL Vertical Cavity Surface-Emitting Laser Applicable Technologies: MOCVD Lithography Wet Etch/Clean Laser Anneal Ion Beam MBE 3D Inspection ALD
Front-End Semi LSA Laser Spike Anneal EUV Extreme Ultraviolet LSA Demand from Taiwan and China 2017 market share was approx. 40% Melt being qualified for production at 7nm & 5nm EUV Photomask Strong interest from photomask industry LDD-IBD ready for EUV adoption STT-MRAM Well positioned for MRAM ramp with multiple engagements across 3 major customers 3D Inspection Evaluations in process with multiple customers in their fabs Applicable Technologies: MOCVD Lithography Wet Etch/Clean Laser Anneal Ion Beam MBE 3D Inspection ALD STT MRAM Spin Transfer Torque Magnetic Random Access Memory LDD-IBD Low Defect Density Ion Beam Deposition
Scientific & Industrial Applicable Technologies: MOCVD Lithography Wet Etch/Clean Laser Anneal Ion Beam MBE 3D Inspection ALD Good Momentum in Optical Coating Systems Strong Bookings in 2017 Broad-based market demand including industrial lasers, optical components for telecom, and R&D Data Storage Good momentum with 60% bookings growth in 2017 Launched Lancer Ion Beam Etch System A reduced-footprint, R&D-focused, ion-beam etch platform for emerging MEMS and magnetic-sensor applications Lancer Ion Beam Etch System
2018 Priorities Complete Integration of Ultratech Launch New Products Deliver Growth in all 4 Markets Diversify Revenue by End Market Grow Earnings Faster than Revenue 18 is now
Q&A
Back Up & Reconciliation Tables
Note on Reconciliation Tables These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation. These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.
Supplemental InformationGAAP to Non-GAAP Reconciliation Note: Amounts may not calculate precisely due to rounding US$ millions Q3 17 Q4 17 2017 Net Sales $131.9 $143.4 $484.8 GAAP Gross Profit 53.1 58.3 184.3 GAAP Gross Margin 40.2% 40.7% 38.0% Add: Release of inventory fair value step-up for purchase accounting 1.9 0.4 9.7 Add: Share-Based Comp 0.7 0.6 2.5 Add: Depreciation of PP&E fair value step-up for purchase accounting 0.1 0.1 0.4 Non-GAAP Gross Profit $55.8 $59.5 $196.9 Non-GAAP Gross Margin 42.3% 41.5% 40.6% US$ millions, except per share data Q3 17 Q4 17 2017 GAAP Basic EPS (0.47) (0.12) (1.01) GAAP Diluted EPS (0.47) (0.12) (1.01) GAAP Net Income (Loss) (21.9) (5.6) (44.8) Add: Share-Based Comp 6.2 4.4 24.4 Add: Amortization 12.5 13.8 35.5 Add: Restructuring 4.1 2.1 10.0 Add: Acquisition Related 0.8 1.5 13.6 Add: Release of inventory fair value step-up for purchase accounting 1.9 0.4 9.7 Add: Depreciation of PP&E fair value step-up for purchase accounting 0.3 0.3 0.7 Add: Asset Impairment - - 1.1 Add: Accelerated depreciation - - 0.2 Add: Non-Cash Interest Expense 2.7 2.8 10.4 Add: Tax Adjustment from GAAP to Non-GAAP (2.3) (10.6) (37.3) Non-GAAP Net Income (Loss) 4.3 9.1 23.4 Non-GAAP Basic EPS 0.09 0.19 0.53 Non-GAAP Diluted EPS 0.09 0.19 0.53 US$ millions Q3 17 Q4 17 2017 GAAP Net Income (Loss) $(21.9) $(5.6) $(44.8) Add: Share-Based Comp 6.2 4.4 24.4 Add: Amortization 12.5 13.8 35.5 Add: Restructuring 4.1 2.1 10.0 Add: Acquisition Related 0.8 1.5 13.6 Add: Release of inventory fair value step-up for purchase accounting 1.9 0.4 9.7 Add: Depreciation of PP&E fair value step-up for purchase accounting 0.3 0.3 0.7 Add: Asset Impairment - - 1.1 Add: Accelerated depreciation - - 0.2 Add: Interest Expense 4.7 4.7 17.1 Subtract: Tax benefit (1.8) (11.1) (36.1) Non-GAAP Operating Income $6.8 $10.5 $31.3
Q4 2017 GAAP to Non-GAAP Reconciliation Non-GAAP Adjustments In millions, except per share data GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $143.4 $143.4 Gross Profit 58.3 0.6 0.5 59.5 Gross Margin 40.7% 41.5% Research and Development 24.3 (1.0) 23.3 Selling, General, and Administrative and Other 28.5 (2.7) (0.2) 25.6 Net Income (Loss) $(5.6) 4.4 13.8 (3.5) $9.1 Income (Loss) Per Common Share: Basic $(0.12) $0.19 Diluted (0.12) 0.19 Weighted Average Number of Shares: Basic 47.0 47.1 Diluted 47.0 47.2 Other Non-GAAP Adjustments Restructuring 2.1 Acquisition Related 1.5 Release of inventory fair value step-up associated with the Ultratech purchase accounting 0.4 Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 0.3 Non-Cash Interest Expense 2.8 Non-GAAP Tax Adjustment (10.6) Total Other (3.5) Note: Amounts may not calculate precisely due to rounding
2017 GAAP to Non-GAAP Reconciliation Non-GAAP Adjustments In millions, except per share data GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $484.8 $484.8 Gross Profit 184.3 2.5 10.1 196.9 Gross Margin 38.0% 40.6% Research and Development 82.0 (3.0) 79.0 Selling, General, and Administrative and Other 99.9 (12.9) (0.5) 86.5 Net Income (Loss) $(44.8) 24.4 35.5 8.4 $23.4 Income (Loss) Per Common Share: Basic $(1.01) $0.53 Diluted (1.01) 0.53 Weighted Average Number of Shares: Basic 44.2 44.2 Diluted 44.2 44.5 Other Non-GAAP Adjustments Restructuring 10.0 Acquisition Related 13.6 Release of inventory fair value step-up associated with the Ultratech purchase accounting 9.7 Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 0.7 Asset Impairment 1.1 Accelerated Depreciation 0.2 Non-Cash Interest Expense 10.4 Non-GAAP Tax Adjustment (37.3) Total Other 8.4 Note: Amounts may not calculate precisely due to rounding
Q1 2018 Guidance GAAP to Non-GAAP Reconciliation Non-GAAP Adjustments In millions, except per share data GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $140$165 $140$165 Gross Profit 4758 1 4859 Gross Margin 33%35% 34%36% Net Income (Loss) $(23)$(15) 4 13 4 $(2)$6 Income (Loss) per Diluted Share $(0.50)$(0.32) $(0.04)$0.14 GAAP Net Income (Loss) $(23)$(15) Share-Based Compensation 4 Amortization 13 Restructuring 1 Acquisition related expense 1 Interest Expense 5 Income Tax Expense (Benefit) 1 Non-GAAP Operating Income $2$10 Non-GAAP Adjustments Note: Amounts may not calculate precisely due to rounding
U*["JJ M+4P"[K0N_!RJ.0 6K0 M#P]M4!;"[' T[5@
M:)HYK@"(_0"9V0"(V@U)WP"$SMU)_@")\ "J"0"9D@"E=-U54-"IY@!EX
M!F1@ 18 !H?0"(F U)^0")_0UFW="9[@UFL]U6[="%PMUW$MUXSP"%9]"7E]
MUVW-"')MU6Y]UU0-"FT-"G>-V&T-V(DMUY#]"8)=U9[ V(WMUI9=U9'=UHJP
MV9K]"9GPV(7="&WMUYD]U53M"*H]"(0P"( "':0!W(@!W-@!W,P!WT0"'VP
MV[N=!W,0!W$P!W0 W,!]V[<=!V[0!FW !FNP!FS !FT !V_^P ;!/0>T'=UQ
MH ?*_=S,[=QO\ 9R8 =V$ B24-Z24 F2$ F1@-Z58 GE'0GE+0B!,-_TG0?V
M'0AR$ CC'=ZU'0AS$ B H =Z8-O6/=O??>#?70=V BS+=Z%4-Z%$ B3( F!
MD >"( F%\.!Y, D3'@B0$ F08 >0T =SD =Q F00.&C 14D 57< 59@ 57
M\ N_X ,[P -6$ W(\ O1D 6_ 2^X O10 _1X SH@ W9< W1P Q5, S.8%2T
M%S_0\ H%,,B 3 " 3,=R#,<", "&C !@C@ )$.8%@ !E#N8*H !ACN9BG@ '
ML.:2? )D.9SS@ )D ,, &QT [^XBFK,B/+Y@3*&2K*["#*;YL.J>S,H@S+
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MV4 _V*+]"'E-\X_M\S7/U:&]V4B_\7*MVDA="(20"*[-X' ",:-VW,@""C>
M!R.>]<9MWWFPV[^-W'#@!M"]!FV@]FL !W( !W, "1Y^V](-WF^@W&UP]V]@
MV^(M"!=^WNW-WI50"910^!/^X7Y/WX( XAX."?+=!WG@WY !_HMWJ^M![,]
MV]:=]YS_W>'MX8)PWY%@!^7M^!Q>WH0 "84P":H_":0OX2@>^R@>"8T/XBN>
M!;COXS">! 9>M*0=VUMEPMK29NBXG^6MH9-7J1HBZ>
M<,3>[,(WSGP"<((##"(,8X;$+.81BOO$(S@:%\AIYA..:"E**>.(1BQ"-*)1
M!"-NJIKI7$(\HIN$=[8CO$PXQSFL48UQ*G&:3%B"$("H4G%\ESO>$8]XSZ'J
M\(*'/$S,1GE&6EXA;&,_\[ '1^Q13Q[*@SWMK74_]AD1?ORSO0'Y!Q+J.9^!
ML*=6!F5I1G. PX0$00GSH&<.@;"?]P21(A>)CT5\D% LT!.2HR( ,E6*
M4VL'VIB/V!&'V<"-\Y@@HWJ.H)(.$[R.GRH.Y"">W>&=H-(=HS)!I(*.H&*>
M97N>=R#^.?5@'G.SMJRR-MN0!L(@+ $I$%4( A0@ 1,H@110@O+(!>[!#W*H
MAK:ZGE1[!?PI!WFP#N?8J7KS*P!@ "6 AN[9A6HHK&H0E$"I'@J2K"!Q0R$Q
MDN7HG^4@DXH;HB<1L'I>R@)"W"M:I((S>B(TF2+1;:B46"BAMTBD2B5:DUQUHC1K1\(
MPX_YF(83.9* &!]8P^H:F5#A:GVPPY*F&)US:;'6F:"C4J*#%JZ6!Y;9!X)P
M9?F;E)S#E]'Z.L::@VP9K?B'Q;41&[0A"( 0%6QI;8G ","A5 \"'_YL$:UI(H7,$M\0B/IJ!2#- )
MJ( *8,4JM ("(;#3 "JTW)'G9H_6MX)
M^J-'C1Y]ZO1)^R=0H+AOY_[(S!@R9,!X,8.H4:-.GCQ=]_3)T2=&F#!9PF\)
ME/U,W>T7DL0_^^S;#Q1+),&DP/TP4421111AA!%"!J&P$$(( 21#.=Z00PXX
MWCBCC!#.V ##3! T<0-REBC#1'^V @!#SQ"+$,##3:PT0,1=N11!SIV_)%'
M(7<$84
1!+,7B)UE\K%.0CNI0G^6PK.O1N>SP1:';CF TG_,P
M@T-X4?=(NM9R!'#,#]]:$$SH#U"8QDI@4DF0A+*[#_RHA$GXK2DM.[5[D.2:
M$.JK/@4:A#_($#U @S-XQYGLE)S$@ W W_D@QVI1^H*+_&"E#:( R2ITXI\
M$1R"R(-$R/LB$C70/"2)R(A$DB.1R$)](3:P/46U/4"EH1_Z2#/9O32IH36Q
MO#2)/1WQ$I8$23-)28+<$B[1HBJY$1R921R)E+L;+Q0IL2]HE#1"E#50@S@-
M+Q@#%:-LRC\XRCK@U4/@U4!*A$7^"$<#\KY3 3]($(1&VI5'VDHIR()DH (D
M@ (MD+(J@\XLPPG F19?N!:N\(4R.[/] Y=;@ 98J,M]&